Form 4 for EWTX Edgewise Therapeutics, Inc.
Accepted 2022-01-25 00:00:00 ET · period of report 2022-01-21 · accession 0001562180-22-000645 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-25 | 2022-01-21 | EWTX | MOORE JOHN R | GC | M - OptEx | $0.71 | +5,400 | 12.4K | +78% | +$3,834 |
| D | 2022-01-25 | 2022-01-21 | EWTX | MOORE JOHN R | GC | M - OptEx | $0.00 | -5,400 | 205.3K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-21 | M | A | 5,400 | $0.71 | 12,362 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-01-21 | M | D | 5,400 | $0.00 | 205,322 | D | $0.71 · — to 2030-09-01 | 5,400 Common Stock | (F1) 1/4th of the shares subject to the option became vested and exercisable on September 1, 2021 and 1/48th of the shares subject to the option continue to vest each month, subject to the Reporting Person continuing as a service provider through each vest date. |